237.27
+5.69(+2.46%)
Currency In USD
| Previous Close | 231.58 |
| Open | 231 |
| Day High | 238.53 |
| Day Low | 231 |
| 52-Week High | 260.49 |
| 52-Week Low | 164.12 |
| Volume | 949,490 |
| Average Volume | 915,138 |
| Market Cap | 34.83B |
| PE | 31.43 |
| EPS | 7.55 |
| Moving Average 50 Days | 242.57 |
| Moving Average 200 Days | 219.75 |
| Change | 5.69 |
If you invested $1000 in ResMed Inc. (RMD) 10 years ago, it would be worth $4,681.6 as of December 21, 2024 at a share price of $237.27. Whereas If you bought $1000 worth of ResMed Inc. (RMD) shares 5 years ago, it would be worth $1,566.05 as of December 21, 2024 at a share price of $237.27.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
ResMed Announces Participation in the UBS Global Healthcare Conference
GlobeNewswire Inc.
Nov 05, 2024 9:05 PM GMT
SAN DIEGO, Nov. 05, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, Chairman and Chief Executive Officer, and Dr. Carlos Nunez, Chief Medical Officer, will participate in a fireside chat at the UBS Global Healthc
ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2025
GlobeNewswire Inc.
Oct 24, 2024 8:05 PM GMT
Year-over-year revenue grows 11%, operating profit up 34%, non-GAAP operating profit up 27%Operating cash flow of $326 million Note: A webcast of ResMed’s conference call will be available at 4:30 p.m. ET today at http://investor.resmed.com SAN DIEGO
ResMed to Report First Quarter Fiscal 2025 Earnings on October 24, 2024
GlobeNewswire Inc.
Oct 03, 2024 8:05 PM GMT
SAN DIEGO, Oct. 03, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the first quarter of fiscal year 2025 on Thursday, October 24, 2024, after the New York Stock Exchan